Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

LAM Pilot Study With Imatinib Mesylate

Trial Profile

LAM Pilot Study With Imatinib Mesylate

Phase of Trial: Phase I/II

Latest Information Update: 29 Jan 2019

At a glance

  • Drugs Imatinib (Primary) ; Everolimus; Sirolimus
  • Indications Lymphangioleiomyomatosis
  • Focus Therapeutic Use
  • Acronyms LAMP-1
  • Most Recent Events

    • 18 Jan 2019 Planned End Date changed from 31 Jan 2019 to 29 Jun 2019.
    • 18 Jan 2019 Planned primary completion date changed from 31 Dec 2018 to 29 Mar 2019.
    • 04 May 2018 Planned End Date changed from 30 Jun 2018 to 31 Jan 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top